- Category
- Small (2024-25)
- Udyam number
- UDYAM-DL-11-0013033

Sarika Life Sciences Private Limited
About Sarika Life Sciences Private Limited
Data last updated:
Sarika Life Sciences Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 04 July 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2017PTC320129. Its GSTIN is 07AAYCS8962L1Z4 (Delhi).
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹15 Lakh. It is led by directors Saksham Sabharwal and Sanchita Sabharwal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 234 2nd Floor Vishal Tower District Centre Janak Puri, New Delhi, Delhi, India – 110058.
As per the financials filed for FY 2025, the company reported a revenue of ₹11.89 Cr, a growth of 77% compared to the previous year. For the same year it recorded a net profit of ₹25.47 Lakh (net margin 2.1%) and EBITDA of ₹44.09 Lakh (EBITDA margin 3.7%). Revenue has grown at a compounded annual rate (CAGR) of 8% over three years and 55% over five years.
As per MCA filings, the company has open charges of ₹5 Cr on record.
Sarika Life Sciences Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-11-0013033). The current compliance status is marked as compliant by the Registrar of Companies.
Recognitions & Rankings of Sarika Life Sciences
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address234 2nd Floor Vishal Tower District Centre Janak Puri, New Delhi, Delhi, India – 110058
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Sarika Life Sciences Private Limited
The main business activity of Sarika Life Sciences is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Sarika Life Sciences Private Limited FY 2025 filings available
Sarika Life Sciences Private Limited reported revenue of ₹11.89 Cr (up 77% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Sarika Life Sciences Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 55% over five years, including 77% growth in the latest year. EBITDA rose 34% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Sarika Life Sciences Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹44.09 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹25.47 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Sarika Life Sciences Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 2.1% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Sarika Life Sciences are in the company report.
Financial statements from FY 2018
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Sarika Life Sciences Private Limited
Sarika Life Sciences has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Saksham Sabharwal | Director | 27 Jul 2021 | 5 Years 2 Months | Current |
| Sanchita Sabharwal | Director | 04 Jul 2017 | 9 Years 3 Months | Current |
Peer Comparison of Sarika Life Sciences Private Limited
Sarika Life Sciences Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Wholesale Trading). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| M R G Consultants Private Limited | ₹11.9 Cr (FY 2025) | •••• | •••• | -7.0% | •••• | Ghaziabad, Uttar Pradesh, India |
| Aste Enterprises Private Limited | ₹11.9 Cr (FY 2025) | •••• | •••• | -47.0% | •••• | New Delhi, Delhi, India |
| SB Composites Private Limited | ₹11.9 Cr (FY 2024) | •••• | •••• | 17.0% | •••• | Chennai, Tamil Nadu, India |
| M K Mobiles Private Limited | ₹11.9 Cr (FY 2025) | •••• | •••• | -10.0% | •••• | Hyderabad, Telangana, India |
| Filsilpek Solutions Private Limited | ₹11.9 Cr (FY 2024) | •••• | •••• | 53.0% | •••• | Ahmedabad, Gujarat, India |
| Sarika Life Sciences Private Limited this company | ₹11.89 Cr (FY 2025) | •••• | •••• | 77.0% | •••• | New Delhi, Delhi, India |
| Geodigital Media Private Limited | ₹11.89 Cr (FY 2024) | •••• | •••• | 29.0% | •••• | Delhi, India |
| Jayniaa Corporation Private Limited | ₹11.89 Cr (FY 2025) | •••• | •••• | 433.0% | •••• | Ahmedabad, Gujarat, India |
| Vyoma Decors Private Limited | ₹11.89 Cr (FY 2024) | •••• | •••• | 59.0% | •••• | Delhi, India |
| S.N. Biri Factory Private Limited | ₹11.89 Cr (FY 2025) | •••• | •••• | 29.0% | •••• | Murshidabad, West Bengal, India |
| Raj Pal Agro India Private Limited | ₹11.89 Cr (FY 2022) | •••• | •••• | 12.0% | •••• | Faridkot, Punjab, India |
Peers are the five companies nearest above and the five nearest below Sarika Life Sciences by revenue in the same principal business activity (Wholesale Trading), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Sarika Life Sciences Private Limited
Sarika Life Sciences Private Limited is audited by J S SACHDEVA & CO for the financial year 2019.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| J S SACHDEVA & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Sarika Life Sciences Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Sarika Life Sciences Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Apr 2024 | Others | ₹5 Cr | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Sarika Life Sciences Private Limited
Employment history and EPFO contributions of people linked to Sarika Life Sciences.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Sarika Life Sciences Private Limited
Sarika Life Sciences Private Limited has 4 board changes on record since 2017: 2 appointments and 2 cessations. The latest: Saksham Sabharwal ceased to be Additional Director on 29 Nov 2021.
Credit Ratings, Litigation & Regulatory Alerts for Sarika Life Sciences Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Sarika Life Sciences Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Sarika Life Sciences Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Sarika Life Sciences Private Limited
Sarika Life Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAYCS8962L1Z4 | Delhi | Active | 19 Oct 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Sarika Life Sciences Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sarika Life Sciences Private Limited
Sarika Life Sciences is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 04 July 2017 (9+ years old) and is registered under CIN U74999DL2017PTC320129.
Sarika Life Sciences reported revenue of ₹11.89 Cr for FY 2025 (up 77% YoY).
Sarika Life Sciences has 2 current directors:
- Saksham Sabharwal - Director
- Sanchita Sabharwal - Director
Sarika Life Sciences reported a net profit of ₹25.47 Lakh (net margin 2.1%) and EBITDA of ₹44.09 Lakh (EBITDA margin 3.7%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Sarika Life Sciences is -8% over three years and 55% over five years. In the latest year (FY 2025) revenue rose 77%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Sarika Life Sciences is 07AAYCS8962L1Z4, registered in Delhi.
The CIN (Corporate Identification Number) of Sarika Life Sciences is U74999DL2017PTC320129. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sarika Life Sciences was incorporated on 04 July 2017, making it 9+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Sarika Life Sciences by revenue are M R G Consultants Private Limited, Aste Enterprises Private Limited, SB Composites Private Limited, M K Mobiles Private Limited, Filsilpek Solutions Private Limited and 5 more, all in the same principal business activity (Wholesale Trading).
Saksham Sabharwal ceased to be Additional Director on 29 Nov 2021. Sarika Sabharwal ceased to be Director on 31 Jul 2021. Saksham Sabharwal was appointed as Director on 27 Jul 2021. Sarika Life Sciences has 4 board changes on record in total.
Yes, Sarika Life Sciences is registered as a small enterprise under Udyam registration (number: UDYAM-DL-11-0013033).